This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
David Haussler: What Can We Learn From Sequencing Our Genomes?
January 29, 2019
Interview with CPA patient
January 29, 2019
Open the windows Poetry & Medicine
January 29, 2019
Bridging the Health Divide in Europe
January 29, 2019
Translational Medicine in Respiratory Disease
January 29, 2019
ERS Vision – Personalising Respiratory Care in Europe
January 29, 2019
Nutritional Science in the Prevention & Management of COPD
January 29, 2019
Designing Drugs to Better Help Real Lives
January 29, 2019
The Lung Health Research & Medicine Revolution
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video